MM&M'S most-read stories of 2017

Topping the list: The MM&M agency issue, the MM&M Awards winners and shortlist, and how a porn star is providing sex ed to seniors

Cancer Research UK 'Right Now' campaign returns to highlight research impact

Cancer Research UK 'Right Now' campaign returns to highlight research impact

Cancer Research UK's 'Right Now' brand campaign will return in 2018 with a new focus highlighting the impact that research has on people suffering with cancer.

MM&M's 5 most-read agency stories of 2017

MM&M's 5 most-read agency stories of 2017

The agency issue, people moves, and a series of restructures top the list.

MM&M 2018 staff predictions: From gift bans to Google Assistant

MM&M 2018 staff predictions: From gift bans to Google Assistant

From gift bans to Google Assistant, POC to OPDP, MM&M staff members give their predictions on what to expect in healthcare marketing in 2018

Open Lens

How can data and analytics help drive better messaging in the pharma industry? Hans Kaspersetz, President of Arteric, chief operating officer and strategist, shares his perspective with Larry Dobrow, MM&M senior editor.

VA reaches out to agencies about recruitment campaign

VA reaches out to agencies about recruitment campaign

The Department of Veteran Affairs issued an RFI at the end of November for a nationwide healthcare professional recruitment campaign.

Five things for pharma marketers to know: Wednesday, December 27, 2017

Five things for pharma marketers to know: Wednesday, December 27, 2017

Mallinckrodt to buy Sucampo for $1.2 billion; Amazon pushes digital advertising in 2018; WHO classifies gaming disorder as mental health condition

Merck comms head Adele Ambrose to retire

Merck comms head Adele Ambrose to retire

VP of investor relations Teri Loxam will take over Ambrose's role in January.

Five things for pharma marketers to know: Tuesday, December 26, 2017

Five things for pharma marketers to know: Tuesday, December 26, 2017

Roche to buy Ignyta for $1.7 billion; FDA OKs Valeant eye drop for OTC sale; Kmart settles prescription drug fraud allegations

Five things for pharma marketers to know: Thursday, December 21, 2017

Five things for pharma marketers to know: Thursday, December 21, 2017

BI to pay $13.5 million for misleading marketing; ICER: CAR-T therapies more cost-effective than chemotherapy; FDA approves Roche's breast cancer combo therapy

Kaiser Permanente hires Kathy Beiser as chief comms officer

Kaiser Permanente hires Kathy Beiser as chief comms officer

Beiser previously held leadership roles at Edelman, Hilton, Discover, and Burson-Marsteller.

Five things for pharma marketers to know: Wednesday, December 20, 2017

Five things for pharma marketers to know: Wednesday, December 20, 2017

Tax bill could lead pharma to move overseas; global pharma sales increased 45% in nine years; FDA OKs first gene therapy for rare retinal disease

Twitter to brands: 280 characters may not be for you

Twitter to brands: 280 characters may not be for you

Brands should refrain from tweets that are over 100 characters, according to Twitter's director of brand strategy.

FDA campaign reframes quitting for smokers

FDA campaign reframes quitting for smokers

The Every Try Counts campaign to change how smokers see their last attempt to quit.

Five things for pharma marketers to know: Tuesday, December 19, 2017

Five things for pharma marketers to know: Tuesday, December 19, 2017

Pharma industry spent $57 million on lobbying in 2016; Humana, private equity firms to buy Kindred for $4 billion; price of old glaucoma drug skyrockets

Five things for pharma marketers to know: Monday, December 18, 2017

Five things for pharma marketers to know: Monday, December 18, 2017

CVS/Aetna deal will affect healthcare benefits; lawmakers pressure DEA to curb painkiller supply; Allergan and Richter's Vraylar sees positive results for bipolar depression

Janssen makes cancer info easy to find on the web

Janssen makes cancer info easy to find on the web

The pharma unit of Johnson & Johnson launched the Cancer.com website this month.

Five things for pharma marketers to know: Thursday, December 14, 2017

Five things for pharma marketers to know: Thursday, December 14, 2017

Pharma R&D return on investment falls to eight-year low; FDA approves Pfizer's biosimilar to J&J's Remicade; Novartis to downsize generics business

Five things for pharma marketers to know: Friday, December 15, 2017

Five things for pharma marketers to know: Friday, December 15, 2017

FDA approves first topical skin growth treatment; Teva to cut 14,000 jobs; Novartis Oncology CEO resigns